- Home
- LNTH vs GBDC Comparison
LNTH vs GBDC Comparison
Compare LNTH & GBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- GBDC
- Stock Information
- Founded
- LNTH 1956
- GBDC 2009
- Country
- LNTH United States
- GBDC United States
- Employees
- LNTH N/A
- GBDC N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- GBDC Finance: Consumer Services
- Sector
- LNTH Health Care
- GBDC Finance
- Exchange
- LNTH Nasdaq
- GBDC Nasdaq
- Market Cap
- LNTH 3.6B
- GBDC 3.9B
- IPO Year
- LNTH 2015
- GBDC 2010
- Fundamental
- Price
- LNTH $58.21
- GBDC $14.78
- Analyst Decision
- LNTH Strong Buy
- GBDC Buy
- Analyst Count
- LNTH 6
- GBDC 3
- Target Price
- LNTH $105.50
- GBDC $15.00
- AVG Volume (30 Days)
- LNTH 2.5M
- GBDC 1.1M
- Earning Date
- LNTH 08-06-2025
- GBDC 08-04-2025
- Dividend Yield
- LNTH N/A
- GBDC 10.82%
- EPS Growth
- LNTH N/A
- GBDC N/A
- EPS
- LNTH 3.77
- GBDC 1.41
- Revenue
- LNTH $1,520,653,000.00
- GBDC $877,342,000.00
- Revenue This Year
- LNTH $4.57
- GBDC $21.93
- Revenue Next Year
- LNTH $9.41
- GBDC N/A
- P/E Ratio
- LNTH $15.42
- GBDC $10.45
- Revenue Growth
- LNTH 5.75
- GBDC 31.97
- 52 Week Low
- LNTH $47.25
- GBDC $12.68
- 52 Week High
- LNTH $118.21
- GBDC $16.01
- Technical
- Relative Strength Index (RSI)
- LNTH 40.12
- GBDC 46.74
- Support Level
- LNTH $55.00
- GBDC $14.57
- Resistance Level
- LNTH $56.16
- GBDC $14.88
- Average True Range (ATR)
- LNTH 2.52
- GBDC 0.17
- MACD
- LNTH 0.57
- GBDC -0.01
- Stochastic Oscillator
- LNTH 41.41
- GBDC 65.12
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About GBDC Golub Capital BDC Inc.
Golub Capital BDC Inc is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and capital appreciation by investing in senior secured and one-stop loans in United States middle-market companies. It also invests in the second lien and subordinated loans, warrants, and minority equity securities in United States middle-market companies. The company generally invests in securities that have been rated below investment grade by independent rating agencies or that would be rated below investment grade if rated. Maximum investment is done in USA and Canadian Companies, with maximum profit earned from those countries.